Image of hexagons overlapping in different sizes

Setting and Revision of Specifications - Regulatory Considerations/expectations; New Challenges, Interplay Between Analytical Test Results, Clinical Testing and Regulatory Expectations (Identification of CQAs)

Home / Papers and Presentations / Resource
AT Europe Analytical technologies in the biopharmaceutical industry

Roundtable 6 Notes: AT Europe 2022
Setting and Revision of Specifications - Regulatory Considerations/expectations; New Challenges, Interplay Between Analytical Test Results, Clinical Testing and Regulatory Expectations (Identification of CQAs)